Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Anna Janina Engstler"'
Autor:
Dragana Rajcic, Annette Brandt, Cheng Jun Jin, Victor Sánchez, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0237946 (2020)
Dietary fat is discussed to be critical in the development of non-alcoholic fatty liver disease. Here, we assess the effect of exchanging dietary fat source from butterfat to extra virgin olive oil on the progression of an already existing diet-induc
Externí odkaz:
https://doaj.org/article/c927ff0d9ee241728c0523ea681b2699
Autor:
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim
Publikováno v:
Nutrients, Vol 13, Iss 3, p 959 (2021)
The addition of plant oils such as soybean oil (S) to a diet rich in saturated fatty acids is discussed as a possible route to prevent or diminish the development of metabolic disease. Here, we assessed whether a butterfat-rich diet fortified with S
Externí odkaz:
https://doaj.org/article/b3616d1e462a480ebd4657fa392caa1c
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0183282 (2017)
BACKGROUND & AIMS:Recent studies have shown that patients with manifest non-alcoholic fatty liver disease (NAFLD), e.g. steatosis grade 3 or steatohepatitis with or without beginning fibrosis frequently show altered fecal microbiota composition and e
Externí odkaz:
https://doaj.org/article/692cc9160f384c87a9e514061153a10c
Autor:
Marcin Krawczyk, Roman Liebe, Ina B. Maier, Anna Janina Engstler, Frank Lammert, Ina Bergheim
Publikováno v:
Gastroenterology Research and Practice, Vol 2015 (2015)
Introduction. The common adiponutrin (PNPLA3) variant p.Ile148Met is associated with liver injury. Here, we investigate the association of this polymorphism with hepatic and metabolic traits in a pediatric cohort. Patients and Methods. The study coho
Externí odkaz:
https://doaj.org/article/256a97cb30c340e8af240a83222bcb60
Autor:
Annette Brandt, Cheng Jun Jin, Katja Nolte, Cathrin Sellmann, Anna Janina Engstler, Ina Bergheim
Publikováno v:
Nutrients, Vol 9, Iss 9, p 1013 (2017)
Intestinal microbiota and barrier functions seem to play an important role in the development of non-alcoholic fatty liver disease (NAFLD). However, whether these changes are an early event in the development of NAFLD or are primarily associated with
Externí odkaz:
https://doaj.org/article/bda33f94983e4fccaa5632639f4b90ff
Autor:
Marianne Hege, Anna Janina Engstler, Annika Höhn, Richard Kehm, Cheng Jun Jin, Otto W. Witte, Annette Brandt, Anika Nier, Christian Schmeer, Anja Baumann, Ina Bergheim, Tilman Grune
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 318:G736-G747
Aging is a risk factor in the development of many diseases, including liver-related diseases. The two aims of the present study were 1) to determine how aging affects liver health in mice in the absence of any interventions and 2) if degenerations ob
Publikováno v:
European Journal of Nutrition
Purpose Results of some epidemiological studies suggest that moderate alcohol consumption may be associated with a decreased risk to develop NAFLD. Here, the effect of the consumption of moderate beer and diluted ethanol, respectively, on the develop
Autor:
Cheng Jun Jin, Dragana Rajcic, Victor Sánchez, Annette Brandt, Anja Baumann, Anna Janina Engstler, Anika Nier, Ina Bergheim, Finn Jung
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 9, p e0237946 (2020)
PLoS ONE, Vol 15, Iss 9, p e0237946 (2020)
Dietary fat is discussed to be critical in the development of non-alcoholic fatty liver disease. Here, we assess the effect of exchanging dietary fat source from butterfat to extra virgin olive oil on the progression of an already existing diet-induc
Autor:
Cheng Jun Jin, Annette Brandt, Anja Baumann, Anna Janina Engstler, Anika Nier, Dragana Rajcic, Victor Sánchez, Finn Jung, Ina Bergheim
Publikováno v:
Proceedings of the Nutrition Society. 79
Background and Aims:General overnutrition, and a diet rich in fat and sugar are among the key risk factors for the development of metabolic diseases including diabetes type 2 and non-alcoholic fatty liver diseases (NAFLD). While being among the most
Publikováno v:
Alcohol and Alcoholism. 52:i31-i49